Most women do not reconstruct their breast(s) post-mastectomy. The experiences of younger women who maintain this decision, although important to understand, are largely absent in the research literature. This interview-based study uses interpretative phenomenological analysis to explore the experiences of six women, diagnosed with primary breast cancer in their 30s/40s, who decided against delayed reconstruction. Findings reported here focus on one superordinate theme (decision-making) from a larger analysis, illustrating that the women’s drive to survive clearly influenced their initial decision-making process. Their tenacity in maintaining their decision is highlighted, despite non-reconstruction sometimes being presented negatively by medical teams. Patient-centred support recommendations are made.
Since 1996 Interpretative Phenomenological Analysis (IPA) has grown rapidly and been applied in areas outside its initial “home” of health psychology. However, explorations of its application from a researcher's perspective are scarce. This paper provides reflections on the experiences of eight individual researchers using IPA in diverse disciplinary fields and cultures. The research studies were conducted in the USA, Malaysia, Australia, New Zealand, Ireland and the UK by researchers with backgrounds in business management, consumer behaviour, mental health nursing, nurse education, applied linguistics, clinical psychology, health and education. They variously explored media awareness, employee commitment, disengagement from mental health services, in-vitro fertilisation treatment, student nurses' experience of child protection, second language acquisition in a university context, the male experience of spinal cord injury and academics experience of working in higher education and women’s experiences of body size and health practices. By bringing together intercultural, interdisciplinary experiences of using IPA, the paper discusses perceived strengths and weaknesses of IPA.
The double hermeneutic is a central feature of interpretative phenomenological analysis (IPA). Typically, this has been considered in relation to individual researchers working with experiential accounts from individual participants. IPA has, however, frequently been applied by multiple researchers; a further layer of complexity occurs when individual or multiple researchers analyse data from group interactions. Little attention has been paid to hermeneutic considerations in these contexts. We present insights into our encounters with multiple hermeneutics as well as our application of the hermeneutic circle; we also consider implications for IPA research. Our multi-vocal approach to analysis requires us to work in a much more integrative manner than is generally represented in IPA literature. Explicitly attending to multiple hermeneutics in focus group situations provides additional insights into the social and cultural contexts within which participants’ experiences exist. This article discusses how the inclusion of multiple hermeneutics adds richness and robustness to IPA.
This study explores the role of others in supporting younger women who opt not to reconstruct their breast post-mastectomy. Semi-structured interviews were conducted with six women, diagnosed with breast cancer in their 30s/40s. The women lived in England, had been diagnosed a minimum of 5 years previously and had undergone unilateral mastectomy.An interpretative phenomenological analysis revealed three themes; Assuring the self: "I'll love you whatever", Challenging the self: 'Do you mean I'm not whole?', and Accepting the self: 'I've come out the other side'. The women's experiences of positive support and challenges to their sense of self are discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.